Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease

Amelyoid-β peptide (Aβ) is a major causative agent responsible for Alzheimer's disease (AD). Aβ contains a high affinity metal binding site that modulates peptide aggregation and toxicity. Therefore, identifying molecules targeting this site represents a valid therapeutic strategy. To test this...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Barnham, Kevin J., Kenche, Vijaya B., Ciccotosto, Giuseppe D., Smith, David P., Tew, Deborah J., Liu, Xiang, Perez, Keyla, Cranston, Greg A., Johanssen, Timothy J., Volitakis, Irene, Bush, Ashley I., Masters, Colin L., White, Anthony R., Smith, Jeffrey P., Cherny, Robert A., Cappai, Roberto
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2008
Teme:
Physical Sciences
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2383936/
https://ncbi.nlm.nih.gov/pubmed/18463291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0800712105
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items